Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Micheau

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Expert Opinion on Therapeutic Targets|July 30, 2003
Cellular FLICE-inhibitory protein: an attractive therapeutic target?Olivier Micheau
International Journal of Molecular Sciences|March 3, 2018
Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by GlycosylationOlivier Micheau
Cancer Letters|November 13, 2010
Targeting c-FLIP in cancerSarah Shirley, Olivier Micheau
Antibodies (Basel, Switzerland)|September 25, 2019
Antibodies and Derivatives Targeting DR4 and DR5 for Cancer TherapyAgathe Dubuisson, Olivier Micheau
Cell|July 31, 2003
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexesOlivier Micheau, Jürg Tschopp
Cells|March 27, 2024
TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic SignallingAbderrahmane Guerrache, Olivier Micheau
British Journal of Pharmacology|August 12, 2009
Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancerStuart A Rushworth, Olivier Micheau
Cellular and Molecular Life Sciences : CMLS|May 29, 2010
Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells?Guillaume Jacquemin, Sarah Shirley, Olivier Micheau
Recent Patents on Anti-Cancer Drug Discovery|July 16, 2011
Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussionSarah Shirley, Alexandre Morizot, Olivier Micheau
Cancers|June 29, 2019
Epigenetic Regulation of TRAIL Signaling: Implication for Cancer TherapyMohammed I Y Elmallah, Olivier Micheau
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Expert Opinion on Therapeutic Targets|July 30, 2003
Cellular FLICE-inhibitory protein: an attractive therapeutic target?Olivier Micheau
International Journal of Molecular Sciences|March 3, 2018
Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by GlycosylationOlivier Micheau
Cancer Letters|November 13, 2010
Targeting c-FLIP in cancerSarah Shirley, Olivier Micheau
Antibodies (Basel, Switzerland)|September 25, 2019
Antibodies and Derivatives Targeting DR4 and DR5 for Cancer TherapyAgathe Dubuisson, Olivier Micheau
Cell|July 31, 2003
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexesOlivier Micheau, Jürg Tschopp
Cells|March 27, 2024
TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic SignallingAbderrahmane Guerrache, Olivier Micheau
British Journal of Pharmacology|August 12, 2009
Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancerStuart A Rushworth, Olivier Micheau
Cellular and Molecular Life Sciences : CMLS|May 29, 2010
Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells?Guillaume Jacquemin, Sarah Shirley, Olivier Micheau
Recent Patents on Anti-Cancer Drug Discovery|July 16, 2011
Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussionSarah Shirley, Alexandre Morizot, Olivier Micheau
Cancers|June 29, 2019
Epigenetic Regulation of TRAIL Signaling: Implication for Cancer TherapyMohammed I Y Elmallah, Olivier Micheau
Pageof 7